Nasdaq · CIK 0001898601
IPX IPERIONX Ltd
Insider trading from SEC Form 4. Last filing Jul 15, 2026. Close $16.48 on Oct 9, 2026, +8% from the 52-week low and -73% from the high.
In brief
IPERIONX Ltd (IPX) has 19 SEC Form 4 filings on file from 7 insiders, the latest filed on Jul 15, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
8 open-market trades have been scored at IPX. The newest: Anastasios Arima (Chief Executive Officer) bought $497k of stock on Jul 10, 2026, filed Jul 13, 2026, scored 64 (notable). The largest of the 8 shown: Todd Hannigan (Executive Chairman) bought $2.1M on Apr 28, 2026, scored 66 (notable). 2 insiders bought within 14 days of each other around Jul 10, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at IPERIONX Ltd, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | Anastasios Arima Chief Executive Officer buy | $497k 138,720 shares | +1% | +14% from low-58% from high | |
| 66Notable | Todd Hannigan Executive Chairman buy | $1.9M 525,000 shares | +2% | +14% from low-58% from high | |
| 59Moderate | Anastasios Arima Chief Executive Officer buy | $494k 110,000 shares | +1% | +53% from low-49% from high | |
| 66Notable | Todd Hannigan Executive Chairman buy | $2.1M 480,000 shares | +2% | +53% from low-49% from high | |
| 65Notable | Anastasios Arima Chief Executive Officer buy | $1.8M 479,800 shares | +4% | - | |
| 46Moderate | Todd Hannigan Executive Chairman buy | $721k 225,225 shares | +1% | - | |
| 48Moderate | R Tony Tripeny director buy | $99k 4,187 shares | - | - | |
| 56Moderate | Toby Edgcumbe Symonds President buy | $263k 11,000 shares | - | - |
Transactions
Every row filed, 31 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Beverly Wyse director | MOption exercise IPX Ordinary Shares | +106,093 | $0.87 | $92k | 745,868 | Jul 15, 2026 |
| Jul 15, 2026 | Beverly Wyse director | XIn-the-money exercise Options to acquire IPX Ordinary Sharesderivative | -106,093 | $0.87 | $92k | 0 | Jul 15, 2026 |
| Jul 14, 2026 | R Tony Tripeny director | POpen-market purchase American Depository Shares (ADS)derivative | +3,846 | $26.00 | $100k | 8,033 | Jul 15, 2026 |
| Jul 10, 2026 | Anastasios Arima Chief Executive Officer | POpen-market purchase IPX Ordinary Shares | +138,720 | $3.58 | $497k | 12,455,502 | Jul 13, 2026 |
| Jul 10, 2026 | Todd Hannigan Executive Chairman | POpen-market purchase IPX Ordinary Shares | +225,000 | $3.58 | $805k | 26,333,334 | Jul 13, 2026 |
| Jul 13, 2026 | Todd Hannigan Executive Chairman | POpen-market purchase IPX Ordinary Shares | +300,000 | $3.59 | $1.1M | 26,633,334 | Jul 13, 2026 |
| Jul 10, 2026 | Toby Edgcumbe Symonds President | POpen-market purchase American Depository Shares (ADS)derivative | +2,040 | $24.55 | $50k | 39,040 | Jul 13, 2026 |
| Jul 10, 2026 | Lorraine M Martin director | POpen-market purchase American Depository Shares (ADS)derivative | +4,100 | $24.51 | $100k | 8,855 | Jul 13, 2026 |
| Apr 28, 2026 | Anastasios Arima Chief Executive Officer | POpen-market purchase Ordinary Shares | +110,000 | $4.49 | $494k | 12,316,782 | Apr 30, 2026 |
| Apr 2, 2026 | Marcela Rocha Castro Chief Financial Officer | AGrant or award Restricted Stock Units (RSUs) | +52,258 | - | - | 214,259 | Apr 30, 2026 |
| Apr 28, 2026 | Toby Edgcumbe Symonds President | POpen-market purchase American Depository Shares (ADS)derivative | +3,000 | $30.63 | $92k | 37,000 | Apr 30, 2026 |
| Apr 28, 2026 | Lorraine M Martin director | POpen-market purchase American Depository Sharesderivative | +4,755 | $31.46 | $150k | 4,755 | Apr 30, 2026 |
| Apr 2, 2026 | Marcela Rocha Castro Chief Financial Officer | AGrant or award Options (A$11)derivative | +127,993 | - | - | 127,993 | Apr 30, 2026 |
| Apr 28, 2026 | Todd Hannigan Executive Chairman | POpen-market purchase Ordinary Shares | +220,000 | $4.48 | $986k | 25,848,334 | Apr 29, 2026 |
| Apr 29, 2026 | Todd Hannigan Executive Chairman | POpen-market purchase Ordinary Shares | +260,000 | $4.20 | $1.1M | 26,108,334 | Apr 29, 2026 |
| Apr 2, 2026 | Marcela Rocha Castro Chief Financial Officer | AGrant or award Restricted Stock Units | +52,258 | - | - | 214,259 | Apr 2, 2026 |
| Apr 2, 2026 | Marcela Rocha Castro Chief Financial Officer | AGrant or award Options (A$11)derivative | +127,993 | - | - | 127,993 | Apr 2, 2026 |
| Apr 2, 2026 | Anastasios Arima Chief Executive Officer | AGrant or award Performance Rights (A$18)derivative | +237,944 | - | - | 237,944 | Apr 2, 2026 |
| Apr 2, 2026 | Todd Hannigan Executive Chairman | AGrant or award Performance Rights (A$18)derivative | +196,086 | - | - | 196,086 | Apr 2, 2026 |
| Apr 2, 2026 | Anastasios Arima Chief Executive Officer | AGrant or award Options (A$18)derivative | +564,759 | $18.00 | $10M | 564,759 | Apr 2, 2026 |
| Apr 2, 2026 | Todd Hannigan Executive Chairman | AGrant or award Options (A$18)derivative | +465,410 | - | - | 465,410 | Apr 2, 2026 |
| Apr 2, 2026 | Toby Edgcumbe Symonds President | AGrant or award Performance Rights (A$18)derivative | +226,047 | - | - | 226,047 | Apr 2, 2026 |
| Apr 2, 2026 | Anastasios Arima Chief Executive Officer | AGrant or award Options (A$22)derivative | +639,205 | $22.00 | $14M | 639,205 | Apr 2, 2026 |
| Apr 2, 2026 | Toby Edgcumbe Symonds President | AGrant or award Options (A$18)derivative | +536,521 | - | - | 536,521 | Apr 2, 2026 |
| Apr 2, 2026 | Todd Hannigan Executive Chairman | AGrant or award Options (A$22)derivative | +526,760 | - | - | 526,760 | Apr 2, 2026 |
| Apr 2, 2026 | Toby Edgcumbe Symonds President | AGrant or award Options (A$22)derivative | +607,244 | - | - | 607,244 | Apr 2, 2026 |
| Mar 27, 2026 | Anastasios Arima Chief Executive Officer | POpen-market purchase Ordinary Shares | +467,000 | $3.20 | $1.5M | 12,206,782 | Mar 30, 2026 |
| Mar 27, 2026 | Todd Hannigan Executive Chairman | POpen-market purchase Ordinary Shares | +225,225 | $3.20 | $721k | 25,628,334 | Mar 30, 2026 |
| Mar 27, 2026 | R Tony Tripeny director | POpen-market purchase American Depository Shares | +4,187 | $23.76 | $99k | 4,187 | Mar 30, 2026 |
| Mar 27, 2026 | Toby Edgcumbe Symonds President | POpen-market purchase American Depository Shares | +11,000 | $23.87 | $263k | 11,000 | Mar 30, 2026 |
| Mar 27, 2026 | Anastasios Arima Chief Executive Officer | POpen-market purchase American Depository Shares | +12,800 | $23.41 | $300k | 12,800 | Mar 30, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Anastasios ArimaChief Executive Officer
- Marcela Rocha CastroChief Financial Officer
- Todd HanniganExecutive Chairman
- Lorraine M Martindirector
- Toby Edgcumbe SymondsPresident
- R Tony Tripenydirector
- Beverly Wysedirector
Questions about IPX
Answered from the filings on this page, as of the latest one.
Are insiders buying IPX?
No. In the last 90 days no insider at IPERIONX Ltd bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade IPX on the open market?
Anastasios Arima (Chief Executive Officer) bought $497k of IPX on Jul 10, 2026 and filed the Form 4 on Jul 13, 2026. InsiderTell scored 64 (notable), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at IPERIONX Ltd?
7 people have filed a Form 4 at IPERIONX Ltd, among them Anastasios Arima (Chief Executive Officer), Marcela Rocha Castro (Chief Financial Officer), Todd Hannigan (Executive Chairman). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.